Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aksam Yassin

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 12, 2017
Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data registerAksam Yassin, Mahmoud Salman, Riadh A Talib, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 9, 2016
Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parametersAksam Yassin, Joanne E Nettleship, Raidh A Talib, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 14, 2017
Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapyMahmoud Salman, Dany-Jan Yassin, Huda Shoukfeh, et al.
The Journal of Urology|July 2, 2014
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registriesAhmad Haider, Michael Zitzmann, Gheorghe Doros, et al.
The Journal of Sexual Medicine|January 21, 2006
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensivesHermann van Ahlen, Klaus Wahle, Wolfram Kupper, et al.
The Journal of Sexual Medicine|September 1, 2006
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunctionDan Ziegler, Frank Merfort, Hermann Van Ahlen, et al.
Vascular Health and Risk Management|July 2, 2016
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry studyAhmad Haider, Aksam Yassin, Karim Sultan Haider, et al.
Andrologia|June 1, 2021
HbA1c over 8.5% is not predictive of increased infection rate following penile prosthesis implant surgery in diabetic patients with erectile dysfunctionRaidh Talib, Ibrahim Alnadhari, Onder Canguven, et al.
Diabetes Care|March 14, 2019
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry StudyAksam Yassin, Ahmad Haider, Karim S Haider, et al.
Reviews in Medical Virology|September 3, 2022
Testosterone and Covid-19: An updateAksam Yassin, Ridwan Shabsigh, Raed M Al-Zoubi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 12, 2017
Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data registerAksam Yassin, Mahmoud Salman, Riadh A Talib, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 9, 2016
Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parametersAksam Yassin, Joanne E Nettleship, Raidh A Talib, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 14, 2017
Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapyMahmoud Salman, Dany-Jan Yassin, Huda Shoukfeh, et al.
The Journal of Urology|July 2, 2014
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registriesAhmad Haider, Michael Zitzmann, Gheorghe Doros, et al.
The Journal of Sexual Medicine|January 21, 2006
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensivesHermann van Ahlen, Klaus Wahle, Wolfram Kupper, et al.
The Journal of Sexual Medicine|September 1, 2006
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunctionDan Ziegler, Frank Merfort, Hermann Van Ahlen, et al.
Vascular Health and Risk Management|July 2, 2016
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry studyAhmad Haider, Aksam Yassin, Karim Sultan Haider, et al.
Andrologia|June 1, 2021
HbA1c over 8.5% is not predictive of increased infection rate following penile prosthesis implant surgery in diabetic patients with erectile dysfunctionRaidh Talib, Ibrahim Alnadhari, Onder Canguven, et al.
Diabetes Care|March 14, 2019
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry StudyAksam Yassin, Ahmad Haider, Karim S Haider, et al.
Reviews in Medical Virology|September 3, 2022
Testosterone and Covid-19: An updateAksam Yassin, Ridwan Shabsigh, Raed M Al-Zoubi, et al.
Pageof 4